Use patterns of e-cigarettes and cigarettes have changed dramatically in the US during the past 10 years. During this time, newer e-cigarette products have emerged, public perceptions have shifted, and both policies and regulations have evolved. In this opening keynote session, Dr. Meza will review recent US trends of cigarette and e-cigarette prevalence and transitions… Read more »
Archives: Seminars
END OF SUMMIT DRINK RECEPTION
PM REFRESHMENT BREAK
LUNCH
AM REFRESHMENT BREAK
The Conversation: A Tale of Two Cities
“It was the best of times, it was the worst of times…” is the famous opening line of Charles Dickens’ historical novel, set during a period of revolution and change. In this session, Tom Glynn will lead a conversation with Ann McNeill and Robin Mermelstein exploring the scientific, cultural and policy questions that e-cigarettes and… Read more »
Is the transition to harm-reduced nicotine products inevitable?
In this presentation, Professor Ron Borland will question if the conventional goal of many in public health to eliminate all nicotine use is achievable, and whether a transition to the use of harm-reduced nicotine products is inevitable. Furthermore, given the enormous cost of smoking, should governments look to facilitate this transition rather than inhibit it?… Read more »
Panel Discussion and Q&A: THR, Cessation & Health
Has the controversy over e-cigarettes been a roadblock to advising current smokers about their choices? and, if so, how could this be corrected? Does long-term e-cigarette use pose more of a public health challenge than a potential relapse to combustible products? Who is responsible for communicating the evidence on the harms of smoking and vaping… Read more »
Panel Discussion and Q&A: Nicotine, Tobacco & Government Policy
Has generic language on “tobacco” products undermined understanding and public communication on the “nicotine harm continuum”? How can high-risk adolescents be considered in the drive to reduce youth? Has a more liberal approach to vaping in other countries reduced smoking? Will there be enough PMTA-approved products to meet adult demand? Are the voices of people… Read more »
Panel Discussion and Q&A: Industry, Society & Nicotine
Is THR a public health principle or an industry strategy? Is nicotine use in society inevitable and if so, should it ever be acceptable? How can the U.S. regulatory and policy process adapt to such a fast-evolving nicotine market? What are the costs of pursuing a policy for a smoke-free and nicotine-free future?
Recent Comments